Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Abraham_Ceesay
|
| gptkbp:focusesOn |
precision medicine
neurological disorders |
| gptkbp:foundedYear |
2022
|
| gptkbp:fundedBy |
$100 million Series A
|
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:program |
targeted therapies for epilepsy
|
| gptkbp:website |
https://www.rapporttherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Third_Rock_Ventures
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rapport Therapeutics
|